ISSN: 1165-158X

細胞および分子生物学

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

NGF and CNTF Expression and Regulation Mechanism by miRNA in Acute Paralytic Strabismus

Hua Liu, Nian Tan, Duo Xu, Chong-Yi Li and Guang-Jun Xian

Nerve growth factor (NGF) and ciliary neurotrophic factor (CNTF) are well known neurotrophic factors and widely used in the clinical treatment for its promotion effect on peripheral nerve regeneration. And they were also recommended for the acute paralytic strabismus treatment. However, whether the NGF and CNTF have protective effect for the extraocular muscles of acute paralytic strabismus patients is still poorly understood. Thus, in this study, we want to evaluate the biological function of NGF and CNTF on the extraocular muscle cells and revealed the regulation mechanism behind it. Firstly, the relative expression of ngf and cntf was assessed by Quantitative Real-time Polymerase Chain Reaction (RT-PCR). Then, the influence of NGF and CNTF on the extraocular muscle cell proliferation was determined by Cell Counting Kit-8 (CCK-8). The inflammatory response in muscle cells after NGF and CNTF treatment was evaluated by ELISA and Reactive Oxygen Species (ROS) detection. In addition to this, the up-stream regulation of the ngf and cntf expression was also studied. The TargetScan was used for the predication of potential miRNAs targeting with ngf and cntf 3’-UTR, which is soon confirmed by luciferase activity assay. Taken together, all the results above indicated that NGF and CNTF could promote the muscle cells proliferation and inhibit the inflammatory levels, then exert protective effect on the muscle cells function. It was conceivable that let 7-5p was the up-stream regulator of ngf and cntf, and let 7-5p might serve as a potential molecular target for acute paralytic strabismus treatment.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。